ADVERTISEMENT
RSV vaccine design concept art
RSV Vaccines That Work?
Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.
RSV Vaccines That Work?
RSV Vaccines That Work?

Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.

Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.

infectious disease, vaccine

a newly hatched mosquito sits on top of water, with its discarded cocoon floating below
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
Katherine Irving | Jan 20, 2023 | 4 min read
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.
Sam Katz looks at the camera
Measles Vaccine Developer Samuel Katz Dies at 95
Lisa Winter | Nov 23, 2022 | 3 min read
He also worked on immunizations against polio, rubella, influenza, and more.
New Strategies in the Battle Against Infectious Diseases
New Strategies in the Battle Against Infectious Diseases
The Scientist Staff | 2 min read
Learn how the latest research into viral and bacterial pathogens advances the prevention and treatment of infectious diseases. 
a person fumigates a red brick pathway to control mosquitoes in the fight against Dengue virus.
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
Katherine Irving | Oct 14, 2022 | 2 min read
In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.
A person in a white shirt activates a nasal spray
Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial
Dan Robitzski | Oct 11, 2022 | 2 min read
Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.
Fast-Tracking COVID-19 Research
The Scientist Creative Services Team in collaboration with Sartorius Corporation | 1 min read
Identifying molecular targets for SARS-CoV-2 therapeutics.
Microscopic image of a poliovirus
Polio Detected in New York City Wastewater
Andy Carstens | Aug 15, 2022 | 2 min read
Analyses suggest the virus has been silently spreading in nearby counties since May.
Artist’s rendition of light blue monkeypox viruses in front of a black background.
FDA To Stretch Monkeypox Vaccine Supply via Intradermal Injection
Shafaq Zia | Aug 12, 2022 | 4 min read
The newly authorized intradermal vaccination only requires one-fifth of the usual vaccine dose. This will help stretch out the limited vaccine supply, experts say, but only if healthcare personnel receive sufficient training.
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
The Scientist | 1 min read
Alessandro Sette and Shane Crotty discuss the T cell response to SARS-CoV-2 and the implications for vaccine design and robust immune memory.
animation showing how proximity affects viral transmission
Monkeypox Likely Spread Undetected in US Before Recent Reports  
Andy Carstens | Jun 6, 2022 | 2 min read
Two strains of monkeypox have been detected in the US, suggesting the virus has been circulating in the country for some time, the CDC says.
Illustration showing rod-shaped Mycobacterium tuberculosis bacteria in the lungs of a person with tuberculosis
Delayed T cell Response Allows Tuberculosis to Gain Foothold in Monkeys
Anna Napolitano, PhD | Jun 1, 2022 | 5 min read
The results could help guide the design of new vaccines for the disease.
photograph of blue surgical masks overlaying one another
The Data Behind the CDC’s New Masking Recommendations
Annie Melchor | Aug 2, 2021 | 2 min read
As a result of massive summer gatherings in and around Cape Cod, hundreds of vaccinated people tested positive for COVID-19 with viral titers similar to unvaccinated patients.
close-up of empty vaccine vials in a factory
The Quest for a Universal Coronavirus Vaccine
Diana Kwon | Jun 29, 2021 | 8 min read
Scientists are on the hunt for a shot that will protect against not only SARS-CoV-2, but other members of its family that may emerge in the future.
New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
Catherine Offord | Apr 26, 2021 | 3 min read
Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso.
Pharma, US Government Plan for COVID-19 Booster Shots
Jef Akst | Apr 16, 2021 | 2 min read
It’s unclear how long protections against infection will last from the initial vaccinations, and health authorities say additional jabs will likely be necessary.
AstraZeneca, University of Oxford, vaccine, COVID-19, SARS-CoV-2, pandemic, coronavirus, vaccination, safety, Europe
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021 | 2 min read
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
COVID-19, coronavirus, SARS-CoV-2, pandemic, virus, vaccine, vaccination, Pfizer, AstraZeneca
COVID-19 Hospitalizations Tank a Month After Vaccines Roll Out
Asher Jones | Feb 23, 2021 | 2 min read
Two preliminary reports from the UK provide real-world evidence in support of the Pfizer/BioNTech and Oxford-AstraZeneca vaccines.
Second Person Dies in Latest Ebola Outbreak in DRC
Catherine Offord | Feb 11, 2021 | 2 min read
The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.
escape mutant vaccine resistance covid-19 sars-cov-2 sars2 coronavirus pandemic evolution variants antibodies neutralizing
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Chris Baraniuk | Feb 4, 2021 | 6 min read
With many millions of people waiting several weeks to receive a second COVID-19 vaccine dose in some countries, experts consider the possibility that SARS-CoV-2 could evolve vaccine resistance.
ADVERTISEMENT